Clinical characteristics and incidence of toxoplasmosis after autologous hematopoietic stem cell transplantation: A retrospective study and literature review
Background Toxoplasmosis is a rare but life‐threatening infection occurring in immunocompromised hosts, including allogeneic hematopoietic stem cell transplantation (allo‐HSCT) recipients. However, thus far, the clinical features and incidence of toxoplasmosis in autologous HSCT (auto‐HSCT) recipien...
Saved in:
| Published in | Transplant infectious disease Vol. 23; no. 6; pp. e13726 - n/a |
|---|---|
| Main Authors | , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Denmark
Wiley Subscription Services, Inc
01.12.2021
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1398-2273 1399-3062 1399-3062 |
| DOI | 10.1111/tid.13726 |
Cover
Loading…
| Abstract | Background
Toxoplasmosis is a rare but life‐threatening infection occurring in immunocompromised hosts, including allogeneic hematopoietic stem cell transplantation (allo‐HSCT) recipients. However, thus far, the clinical features and incidence of toxoplasmosis in autologous HSCT (auto‐HSCT) recipients remain unknown. This retrospective survey aimed to analyze 152 patients who received auto‐HSCT between 1998 and 2017.
Methods
Serological tests for Toxoplasma gondii‐specific IgG were performed on 109 (71.7%) recipients, and 12 pre‐HSCT recipients (11%) were Toxoplasma seropositive. Among the 12 recipients, three who did not receive trimethoprim‐sulfamethoxazole (TMP/SMX) prophylaxis developed cerebral, pulmonary or disseminated toxoplasmosis due to reactivation after auto‐HSCT and died despite treatment.
Results
The incidences of toxoplasmosis were 2% and 25% among 152 auto‐HSCT recipients (five recipients received auto‐HSCT two times) and 12 pre‐HSCT Toxoplasma seropositive recipients, respectively. Further, we conducted a literature review and identified 21 cases of toxoplasmosis following auto‐HSCT. In these previous cases, the mortality rate was high, especially for pulmonary and disseminated toxoplasmosis. Our findings suggest that, similar to toxoplasmosis after allo‐HSCT, toxoplasmosis after auto‐HSCT is a fatal complication.
Conclusions
Serial screening of T. gondii‐specific IgG before HSCT could contribute to the detection of Toxoplasma reactivation and allow for prompt diagnosis and treatment. The present study is the first to reveal the incidence of toxoplasmosis after auto‐HSCT among seropositive patients in Japan. |
|---|---|
| AbstractList | Toxoplasmosis is a rare but life-threatening infection occurring in immunocompromised hosts, including allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. However, thus far, the clinical features and incidence of toxoplasmosis in autologous HSCT (auto-HSCT) recipients remain unknown. This retrospective survey aimed to analyze 152 patients who received auto-HSCT between 1998 and 2017.
Serological tests for Toxoplasma gondii-specific IgG were performed on 109 (71.7%) recipients, and 12 pre-HSCT recipients (11%) were Toxoplasma seropositive. Among the 12 recipients, three who did not receive trimethoprim-sulfamethoxazole (TMP/SMX) prophylaxis developed cerebral, pulmonary or disseminated toxoplasmosis due to reactivation after auto-HSCT and died despite treatment.
The incidences of toxoplasmosis were 2% and 25% among 152 auto-HSCT recipients (five recipients received auto-HSCT two times) and 12 pre-HSCT Toxoplasma seropositive recipients, respectively. Further, we conducted a literature review and identified 21 cases of toxoplasmosis following auto-HSCT. In these previous cases, the mortality rate was high, especially for pulmonary and disseminated toxoplasmosis. Our findings suggest that, similar to toxoplasmosis after allo-HSCT, toxoplasmosis after auto-HSCT is a fatal complication.
Serial screening of T. gondii-specific IgG before HSCT could contribute to the detection of Toxoplasma reactivation and allow for prompt diagnosis and treatment. The present study is the first to reveal the incidence of toxoplasmosis after auto-HSCT among seropositive patients in Japan. BackgroundToxoplasmosis is a rare but life‐threatening infection occurring in immunocompromised hosts, including allogeneic hematopoietic stem cell transplantation (allo‐HSCT) recipients. However, thus far, the clinical features and incidence of toxoplasmosis in autologous HSCT (auto‐HSCT) recipients remain unknown. This retrospective survey aimed to analyze 152 patients who received auto‐HSCT between 1998 and 2017.MethodsSerological tests for Toxoplasma gondii‐specific IgG were performed on 109 (71.7%) recipients, and 12 pre‐HSCT recipients (11%) were Toxoplasma seropositive. Among the 12 recipients, three who did not receive trimethoprim‐sulfamethoxazole (TMP/SMX) prophylaxis developed cerebral, pulmonary or disseminated toxoplasmosis due to reactivation after auto‐HSCT and died despite treatment.ResultsThe incidences of toxoplasmosis were 2% and 25% among 152 auto‐HSCT recipients (five recipients received auto‐HSCT two times) and 12 pre‐HSCT Toxoplasma seropositive recipients, respectively. Further, we conducted a literature review and identified 21 cases of toxoplasmosis following auto‐HSCT. In these previous cases, the mortality rate was high, especially for pulmonary and disseminated toxoplasmosis. Our findings suggest that, similar to toxoplasmosis after allo‐HSCT, toxoplasmosis after auto‐HSCT is a fatal complication.ConclusionsSerial screening of T. gondii‐specific IgG before HSCT could contribute to the detection of Toxoplasma reactivation and allow for prompt diagnosis and treatment. The present study is the first to reveal the incidence of toxoplasmosis after auto‐HSCT among seropositive patients in Japan. Background Toxoplasmosis is a rare but life‐threatening infection occurring in immunocompromised hosts, including allogeneic hematopoietic stem cell transplantation (allo‐HSCT) recipients. However, thus far, the clinical features and incidence of toxoplasmosis in autologous HSCT (auto‐HSCT) recipients remain unknown. This retrospective survey aimed to analyze 152 patients who received auto‐HSCT between 1998 and 2017. Methods Serological tests for Toxoplasma gondii‐specific IgG were performed on 109 (71.7%) recipients, and 12 pre‐HSCT recipients (11%) were Toxoplasma seropositive. Among the 12 recipients, three who did not receive trimethoprim‐sulfamethoxazole (TMP/SMX) prophylaxis developed cerebral, pulmonary or disseminated toxoplasmosis due to reactivation after auto‐HSCT and died despite treatment. Results The incidences of toxoplasmosis were 2% and 25% among 152 auto‐HSCT recipients (five recipients received auto‐HSCT two times) and 12 pre‐HSCT Toxoplasma seropositive recipients, respectively. Further, we conducted a literature review and identified 21 cases of toxoplasmosis following auto‐HSCT. In these previous cases, the mortality rate was high, especially for pulmonary and disseminated toxoplasmosis. Our findings suggest that, similar to toxoplasmosis after allo‐HSCT, toxoplasmosis after auto‐HSCT is a fatal complication. Conclusions Serial screening of T. gondii‐specific IgG before HSCT could contribute to the detection of Toxoplasma reactivation and allow for prompt diagnosis and treatment. The present study is the first to reveal the incidence of toxoplasmosis after auto‐HSCT among seropositive patients in Japan. Toxoplasmosis is a rare but life-threatening infection occurring in immunocompromised hosts, including allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. However, thus far, the clinical features and incidence of toxoplasmosis in autologous HSCT (auto-HSCT) recipients remain unknown. This retrospective survey aimed to analyze 152 patients who received auto-HSCT between 1998 and 2017.BACKGROUNDToxoplasmosis is a rare but life-threatening infection occurring in immunocompromised hosts, including allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. However, thus far, the clinical features and incidence of toxoplasmosis in autologous HSCT (auto-HSCT) recipients remain unknown. This retrospective survey aimed to analyze 152 patients who received auto-HSCT between 1998 and 2017.Serological tests for Toxoplasma gondii-specific IgG were performed on 109 (71.7%) recipients, and 12 pre-HSCT recipients (11%) were Toxoplasma seropositive. Among the 12 recipients, three who did not receive trimethoprim-sulfamethoxazole (TMP/SMX) prophylaxis developed cerebral, pulmonary or disseminated toxoplasmosis due to reactivation after auto-HSCT and died despite treatment.METHODSSerological tests for Toxoplasma gondii-specific IgG were performed on 109 (71.7%) recipients, and 12 pre-HSCT recipients (11%) were Toxoplasma seropositive. Among the 12 recipients, three who did not receive trimethoprim-sulfamethoxazole (TMP/SMX) prophylaxis developed cerebral, pulmonary or disseminated toxoplasmosis due to reactivation after auto-HSCT and died despite treatment.The incidences of toxoplasmosis were 2% and 25% among 152 auto-HSCT recipients (five recipients received auto-HSCT two times) and 12 pre-HSCT Toxoplasma seropositive recipients, respectively. Further, we conducted a literature review and identified 21 cases of toxoplasmosis following auto-HSCT. In these previous cases, the mortality rate was high, especially for pulmonary and disseminated toxoplasmosis. Our findings suggest that, similar to toxoplasmosis after allo-HSCT, toxoplasmosis after auto-HSCT is a fatal complication.RESULTSThe incidences of toxoplasmosis were 2% and 25% among 152 auto-HSCT recipients (five recipients received auto-HSCT two times) and 12 pre-HSCT Toxoplasma seropositive recipients, respectively. Further, we conducted a literature review and identified 21 cases of toxoplasmosis following auto-HSCT. In these previous cases, the mortality rate was high, especially for pulmonary and disseminated toxoplasmosis. Our findings suggest that, similar to toxoplasmosis after allo-HSCT, toxoplasmosis after auto-HSCT is a fatal complication.Serial screening of T. gondii-specific IgG before HSCT could contribute to the detection of Toxoplasma reactivation and allow for prompt diagnosis and treatment. The present study is the first to reveal the incidence of toxoplasmosis after auto-HSCT among seropositive patients in Japan.CONCLUSIONSSerial screening of T. gondii-specific IgG before HSCT could contribute to the detection of Toxoplasma reactivation and allow for prompt diagnosis and treatment. The present study is the first to reveal the incidence of toxoplasmosis after auto-HSCT among seropositive patients in Japan. |
| Author | Uematsu, Nozomu Ueki, Toshimitsu Watanabe, Masahide Hikosaka, Kenji Shishido, Tsutomu Kobayashi, Hikaru Kazumoto, Hiroko Kaiume, Hiroko Kitahara, Mari Hiroshima, Yuki Sato, Keijiro Norose, Kazumi Sumi, Masahiko |
| Author_xml | – sequence: 1 givenname: Mari orcidid: 0000-0003-0586-5014 surname: Kitahara fullname: Kitahara, Mari email: kitaharamari3027@gmail.com organization: Nagano Red Cross Hospital – sequence: 2 givenname: Yuki surname: Hiroshima fullname: Hiroshima, Yuki organization: Nagano Red Cross Hospital – sequence: 3 givenname: Kazumi surname: Norose fullname: Norose, Kazumi organization: Graduate School of Medicine, Chiba University – sequence: 4 givenname: Kenji surname: Hikosaka fullname: Hikosaka, Kenji organization: Graduate School of Medicine, Chiba University – sequence: 5 givenname: Hiroko surname: Kazumoto fullname: Kazumoto, Hiroko organization: Nagano Red Cross Hospital – sequence: 6 givenname: Nozomu surname: Uematsu fullname: Uematsu, Nozomu organization: Nagano Red Cross Hospital – sequence: 7 givenname: Tsutomu surname: Shishido fullname: Shishido, Tsutomu organization: Nagano Red Cross Hospital – sequence: 8 givenname: Hiroko surname: Kaiume fullname: Kaiume, Hiroko organization: Nagano Red Cross Hospital – sequence: 9 givenname: Keijiro surname: Sato fullname: Sato, Keijiro organization: Nagano Red Cross Hospital – sequence: 10 givenname: Toshimitsu surname: Ueki fullname: Ueki, Toshimitsu organization: Nagano Red Cross Hospital – sequence: 11 givenname: Masahiko surname: Sumi fullname: Sumi, Masahiko organization: Nagano Red Cross Hospital – sequence: 12 givenname: Masahide surname: Watanabe fullname: Watanabe, Masahide organization: Suwa Red Cross Hospital – sequence: 13 givenname: Hikaru surname: Kobayashi fullname: Kobayashi, Hikaru organization: Nagano Red Cross Hospital |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34542220$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kc9OHSEYxUmjqXrbRV-gIemmLkYZ_s1Md-ZqWxOTbuyaMMw3FcPAFBj1PkzfVbzXdmFi2UDC7xw-zjlCez54QOhDTU7qsk6zHU5q1lD5Bh3WrOsqRiTd257bitKGHaCjlG4JqZuOd2_RAeOCU0rJIfqzdtZbox02NzpqkyHalK1JWPsBW2_sAN4ADiPO4SHMTqcpJFuux4JiveTgwq-wJHwDk85hDhaKHKcMEzbgHM5R-1R0Putsg_-Cz3CEHEOawWR7BwVdhs32OWeLp85LhILcWbh_h_ZH7RK8f95X6OfXi-v19-rqx7fL9dlVZXjdyYqyQRDJGRjRUz2KfmBtT4TQUgsYhRGEsmbUjAKXMDBO256LtjP12HaUacNW6PPOd47h9wIpq8mmp-m1h_I3RUXDGyZl8VmhTy_Q27BEX6ZTVNZUtl3DeKE-PlNLP8Gg5mgnHTfqb_AFON4BpiSRIoz_kJqop1JVKVVtSy3s6QvW2F2YJVvr_qe4tw42r1ur68vzneIRGYG2Yw |
| CitedBy_id | crossref_primary_10_17816_RFD296574 crossref_primary_10_1007_s40278_022_13838_y crossref_primary_10_3138_jammi_2024_0013 crossref_primary_10_1016_S1473_3099_23_00495_4 |
| Cites_doi | 10.1111/tid.13506 10.1128/JCM.27.8.1787-1792.1989 10.1128/JCM.03282-14 10.1128/JCM.39.1.398-400.2001 10.1038/sj.bmt.1703425 10.1016/j.parint.2012.05.005 10.1016/j.ijantimicag.2006.04.001 10.1086/651266 10.1086/516966 10.1007/s12185-013-1379-8 10.1007/s00277-004-0898-z 10.1086/317471 10.1086/426447 10.1016/S0140-6736(04)16412-X 10.1007/s10096-013-1879-8 10.1212/01.wnl.0000247038.43228.17 10.1111/j.1600-0609.2005.00605.x 10.1093/clinids/19.4.800 10.1111/j.1469-0691.2008.02091.x 10.1097/QCO.0000000000000169 10.1007/s10096-003-0983-6 10.1007/s12185-016-2077-0 10.1097/MPH.0b013e3182677e84 10.1093/ofid/ofw070 10.1128/CMR.00057-17 10.1080/10428190601011564 10.1111/tid.12532 10.1016/j.transproceed.2020.02.068 10.1016/S0140-6736(00)02407-7 10.1128/CVI.05486-11 10.1111/j.1600-0609.2007.00919.x |
| ContentType | Journal Article |
| Copyright | 2021 Wiley Periodicals LLC 2021 Wiley Periodicals LLC. |
| Copyright_xml | – notice: 2021 Wiley Periodicals LLC – notice: 2021 Wiley Periodicals LLC. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QO 7U9 8FD FR3 H94 K9. M7N P64 7X8 |
| DOI | 10.1111/tid.13726 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Biotechnology Research Abstracts Virology and AIDS Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Biotechnology Research Abstracts Technology Research Database Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Virology and AIDS Abstracts MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 1399-3062 |
| EndPage | n/a |
| ExternalDocumentID | 34542220 10_1111_tid_13726 TID13726 |
| Genre | article Journal Article Review |
| GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 123 1OC 29Q 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADMGS ADNMO ADOZA ADXAS ADZCM AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K ROL RX1 SUPJJ SV3 TEORI TUS UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR XG1 YFH YUY ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION CGR CUY CVF ECM EIF NPM 7QO 7U9 8FD AAMMB AEFGJ AGXDD AIDQK AIDYY FR3 H94 K9. M7N P64 7X8 |
| ID | FETCH-LOGICAL-c4196-23d50643ec5b2af5bd38b055a6a5ef5c50237fa32e46ed3428b4589c1f8923ac3 |
| IEDL.DBID | DR2 |
| ISSN | 1398-2273 1399-3062 |
| IngestDate | Fri Jul 11 07:12:50 EDT 2025 Fri Jul 25 21:25:19 EDT 2025 Wed Feb 19 02:27:16 EST 2025 Tue Jul 01 01:27:23 EDT 2025 Thu Apr 24 23:01:16 EDT 2025 Wed Jan 22 16:26:37 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | autologous hematopoietic stem cell transplantation anti-Toxoplasma gondii-specific IgG antibody infection toxoplasmosis incidence |
| Language | English |
| License | 2021 Wiley Periodicals LLC. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4196-23d50643ec5b2af5bd38b055a6a5ef5c50237fa32e46ed3428b4589c1f8923ac3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0003-0586-5014 |
| PMID | 34542220 |
| PQID | 2612689734 |
| PQPubID | 1096379 |
| PageCount | 10 |
| ParticipantIDs | proquest_miscellaneous_2574736602 proquest_journals_2612689734 pubmed_primary_34542220 crossref_primary_10_1111_tid_13726 crossref_citationtrail_10_1111_tid_13726 wiley_primary_10_1111_tid_13726_TID13726 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | December 2021 |
| PublicationDateYYYYMMDD | 2021-12-01 |
| PublicationDate_xml | – month: 12 year: 2021 text: December 2021 |
| PublicationDecade | 2020 |
| PublicationPlace | Denmark |
| PublicationPlace_xml | – name: Denmark – name: Malden |
| PublicationTitle | Transplant infectious disease |
| PublicationTitleAlternate | Transpl Infect Dis |
| PublicationYear | 2021 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | 2012; 61 2004; 363 2004; 83 2017; 4 2000; 355 1995; 15 2006; 76 2015; 53 1997; 25 2000; 85 2008; 14 2005; 40 2012; 19 2020;; 23 2016; 104 2016; 18 1989; 27 2007; 79 2015; 28 2002; 29 2016; 3 2006; 67 2013; 32 1994; 19 2013; 98 2020; 52 2013; 35 2006; 27 2000; 31 2001; 39 2018; 31 2007; 48 2003; 22 2010; 50 e_1_2_8_28_1 e_1_2_8_29_1 e_1_2_8_24_1 e_1_2_8_25_1 e_1_2_8_26_1 e_1_2_8_27_1 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_7_1 e_1_2_8_8_1 Peacock JE (e_1_2_8_11_1) 1995; 15 e_1_2_8_20_1 e_1_2_8_21_1 e_1_2_8_22_1 e_1_2_8_23_1 Amikura T (e_1_2_8_4_1) 2020; 23 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_36_1 e_1_2_8_14_1 e_1_2_8_35_1 e_1_2_8_15_1 e_1_2_8_16_1 Japanese Society for Transplantation and Cellular Therapy (e_1_2_8_6_1) 2017; 4 Nakane M (e_1_2_8_9_1) 2000; 85 e_1_2_8_32_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_34_1 e_1_2_8_12_1 e_1_2_8_33_1 e_1_2_8_30_1 |
| References_xml | – volume: 363 start-page: 1965 year: 2004 end-page: 1976 article-title: Toxoplasmosis publication-title: Lancet – volume: 31 start-page: e00057 year: 2018 end-page: 17 article-title: Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice publication-title: Clin Microbiol Rev – volume: 27 start-page: 1787 year: 1989 end-page: 1792 article-title: Direct and sensitive detection of a pathogenic protozoan, , by polymerase chain reaction publication-title: J Clin Microbiol – volume: 19 start-page: 365 year: 2012 end-page: 367 article-title: Anti‐ antibody prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4,466 pregnant women in Japan publication-title: Clin Vaccine Immunol – volume: 83 start-page: 592 year: 2004 end-page: 595 article-title: infection in patients with hematological malignancies publication-title: Ann Hematol – volume: 23 year: 2020; article-title: Toxoplasmosis after allogeneic hematopoietic stem cell transplantation: impact of serostatus‐based management publication-title: Transpl Infect Dis – volume: 27 start-page: 570 year: 2006 end-page: 572 article-title: Changing the outcome of toxoplasmosis in bone marrow transplant recipients publication-title: Int J Antimicrob Agents – volume: 39 start-page: 398 year: 2001 end-page: 400 article-title: Rapid identification of virulent type I strains of the protozoan pathogen by PCR‐restriction fragment length polymorphism analysis at the gene publication-title: J Clin Microbiol – volume: 40 start-page: 67 year: 2005 end-page: 78 article-title: Early detection of infection by molecular monitoring of in peripheral blood samples after allogeneic stem cell transplantation publication-title: Clin Infect Dis – volume: 14 start-page: 1089 year: 2008 end-page: 1101 article-title: Prevention of toxoplasmosis in transplant patients publication-title: Clin Microbiol Infect – volume: 48 start-page: 201 year: 2007 end-page: 203 article-title: Toxoplasma encephalitis after autologous stem cell transplantation publication-title: Leuk Lymphoma – volume: 31 start-page: 1188 year: 2000 end-page: 1195 article-title: Toxoplasmosis after hematopoietic stem cell transplantation publication-title: Clin Infect Dis – volume: 355 start-page: 2217 year: 2000 end-page: 2218 article-title: Stopping primary prophylaxis in HIV‐1‐infected patients at high risk of toxoplasma encephalitis. Swiss HIV Cohort Study publication-title: Lancet – volume: 85 start-page: 334 year: 2000 end-page: 335 article-title: Disseminated toxoplasmosis after CD34+‐selected autologous peripheral blood stem cell transplantation publication-title: Haematologica – volume: 52 start-page: 2178 year: 2020 end-page: 2185 article-title: Infectious complications in patients with multiple myeloma after high‐dose chemotherapy followed by autologous stem cell transplant: nationwide study of the infectious complications study group of the polish adult leukemia group publication-title: Transplant Proc – volume: 4 start-page: 30 year: 2017 end-page: 37 article-title: Guideline for the hematopoietic stem cell transplantation. Infection control after hematopoietic stem cell transplantation publication-title: Jpn Soc Hematopoietic Cell Transplant Monogr – volume: 104 start-page: 729 year: 2016 end-page: 740 article-title: Clinical characteristics and computed tomography findings of pulmonary toxoplasmosis after hematopoietic stem cell transplantation publication-title: Int J Hematol – volume: 18 start-page: 446 year: 2016 end-page: 452 article-title: Failure of primary atovaquone prophylaxis for prevention of toxoplasmosis in hematopoietic cell transplant recipients publication-title: Transpl Infect Dis – volume: 28 start-page: 283 year: 2015 end-page: 292 article-title: Toxoplasma prophylaxis in haematopoietic cell transplant recipients: a review of the literature and recommendations publication-title: Curr Opin Infect Dis – volume: 53 start-page: 1677 year: 2015 end-page: 1684 article-title: Molecular diagnosis of toxoplasmosis in immunocompromised patients: a 3‐year multicenter retrospective study publication-title: J Clin Microbiol – volume: 32 start-page: 1259 year: 2013 end-page: 1268 article-title: Disseminated toxoplasmosis in non‐allografted patients with hematologic malignancies: report of two cases and literature review publication-title: Eur J Clin Microbiol Infect Dis – volume: 22 start-page: 548 year: 2003 end-page: 550 article-title: Cerebral toxoplasmosis after autologous peripheral blood stem cell transplantation publication-title: Eur J Clin Microbiol Infect Dis – volume: 50 start-page: 1127 year: 2010 end-page: 1134 article-title: Myeloablative conditioning predisposes patients for reactivation after allogeneic stem cell transplantation publication-title: Clin Infect Dis – volume: 61 start-page: 565 year: 2012 end-page: 571 article-title: Determining high‐risk autologous and allogeneic hematopoietic stem cell transplantation patients by systematic pre‐transplant PCR screening of stem cell originated buffy coat publication-title: Parasitol Int – volume: 35 start-page: e50 year: 2013 end-page: 52 article-title: Cerebral toxoplasmosis after tandem high‐dose chemotherapy and autologous hematopoietic cell transplant for neuroblastoma publication-title: J Pediatr Hematol Oncol – volume: 29 start-page: 691 year: 2002 end-page: 698 article-title: Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature publication-title: Bone Marrow Transplant – volume: 98 start-page: 214 year: 2013 end-page: 222 article-title: Acute exacerbation of infection after hematopoietic stem cell transplantation: five case reports among 279 recipients publication-title: Int J Hematol – volume: 19 start-page: 800 year: 1994 end-page: 801 article-title: Disseminated toxoplasmosis following autologous bone marrow transplantation publication-title: Clin Infect Dis – volume: 25 start-page: 1255 year: 1997 end-page: 1256 article-title: Ocular toxoplasmosis after autologous peripheral‐blood stem‐cell transplantation publication-title: Clin Infect Dis – volume: 3 year: 2016 article-title: encephalitis in atypical hosts at an academic cancer center publication-title: Open Forum Infect Dis – volume: 15 start-page: 983 year: 1995 end-page: 987 article-title: Reactivation toxoplasmic retinochoroiditis in patients undergoing bone marrow transplantation: is there a role for chemoprophylaxis? publication-title: Bone Marrow Transplant – volume: 67 start-page: 1990 year: 2006 end-page: 1997 article-title: Spectrum and prognosis of neurologic complications after hematopoietic transplantation publication-title: Neurology – volume: 76 start-page: 245 year: 2006 end-page: 250 article-title: Early treatment‐related mortality in adult autologous stem cell transplant recipients: a nation‐wide survey of 1482 transplanted patients publication-title: Eur J Haematol – volume: 79 start-page: 317 year: 2007 end-page: 321 article-title: Toxoplasmosis encephalitis following severe graft‐vs.‐host disease after allogeneic hematopoietic stem cell transplantation: 17 yr experience in Fukuoka BMT group publication-title: Eur J Haematol – article-title: Hematopoietic cell transplantation in Japan. Annual report of nationwide survey 2020 – volume: 23 start-page: e13506 year: 2020 ident: e_1_2_8_4_1 article-title: Toxoplasmosis after allogeneic hematopoietic stem cell transplantation: impact of serostatus‐based management publication-title: Transpl Infect Dis doi: 10.1111/tid.13506 – ident: e_1_2_8_23_1 doi: 10.1128/JCM.27.8.1787-1792.1989 – ident: e_1_2_8_21_1 doi: 10.1128/JCM.03282-14 – volume: 4 start-page: 30 year: 2017 ident: e_1_2_8_6_1 article-title: Guideline for the hematopoietic stem cell transplantation. Infection control after hematopoietic stem cell transplantation publication-title: Jpn Soc Hematopoietic Cell Transplant Monogr – ident: e_1_2_8_25_1 doi: 10.1128/JCM.39.1.398-400.2001 – ident: e_1_2_8_28_1 doi: 10.1038/sj.bmt.1703425 – ident: e_1_2_8_8_1 doi: 10.1016/j.parint.2012.05.005 – ident: e_1_2_8_12_1 doi: 10.1016/j.ijantimicag.2006.04.001 – ident: e_1_2_8_32_1 doi: 10.1086/651266 – ident: e_1_2_8_20_1 doi: 10.1086/516966 – ident: e_1_2_8_22_1 doi: 10.1007/s12185-013-1379-8 – ident: e_1_2_8_19_1 doi: 10.1007/s00277-004-0898-z – ident: e_1_2_8_3_1 doi: 10.1086/317471 – ident: e_1_2_8_33_1 doi: 10.1086/426447 – ident: e_1_2_8_2_1 doi: 10.1016/S0140-6736(04)16412-X – ident: e_1_2_8_10_1 doi: 10.1007/s10096-013-1879-8 – ident: e_1_2_8_16_1 doi: 10.1212/01.wnl.0000247038.43228.17 – ident: e_1_2_8_31_1 doi: 10.1111/j.1600-0609.2005.00605.x – ident: e_1_2_8_13_1 doi: 10.1093/clinids/19.4.800 – ident: e_1_2_8_26_1 doi: 10.1111/j.1469-0691.2008.02091.x – volume: 15 start-page: 983 year: 1995 ident: e_1_2_8_11_1 article-title: Reactivation toxoplasmic retinochoroiditis in patients undergoing bone marrow transplantation: is there a role for chemoprophylaxis? publication-title: Bone Marrow Transplant – ident: e_1_2_8_5_1 doi: 10.1097/QCO.0000000000000169 – ident: e_1_2_8_17_1 doi: 10.1007/s10096-003-0983-6 – ident: e_1_2_8_24_1 doi: 10.1007/s12185-016-2077-0 – volume: 85 start-page: 334 year: 2000 ident: e_1_2_8_9_1 article-title: Disseminated toxoplasmosis after CD34+‐selected autologous peripheral blood stem cell transplantation publication-title: Haematologica – ident: e_1_2_8_18_1 doi: 10.1097/MPH.0b013e3182677e84 – ident: e_1_2_8_14_1 doi: 10.1093/ofid/ofw070 – ident: e_1_2_8_27_1 doi: 10.1128/CMR.00057-17 – ident: e_1_2_8_15_1 doi: 10.1080/10428190601011564 – ident: e_1_2_8_34_1 doi: 10.1111/tid.12532 – ident: e_1_2_8_30_1 doi: 10.1016/j.transproceed.2020.02.068 – ident: e_1_2_8_35_1 doi: 10.1016/S0140-6736(00)02407-7 – ident: e_1_2_8_36_1 doi: 10.1128/CVI.05486-11 – ident: e_1_2_8_29_1 – ident: e_1_2_8_7_1 doi: 10.1111/j.1600-0609.2007.00919.x |
| SSID | ssj0017949 |
| Score | 2.3139122 |
| SecondaryResourceType | review_article |
| Snippet | Background
Toxoplasmosis is a rare but life‐threatening infection occurring in immunocompromised hosts, including allogeneic hematopoietic stem cell... Toxoplasmosis is a rare but life-threatening infection occurring in immunocompromised hosts, including allogeneic hematopoietic stem cell transplantation... BackgroundToxoplasmosis is a rare but life‐threatening infection occurring in immunocompromised hosts, including allogeneic hematopoietic stem cell... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | e13726 |
| SubjectTerms | Antibiotics anti‐Toxoplasma gondii‐specific IgG antibody Autografts autologous hematopoietic stem cell transplantation Fatalities Hematopoietic Stem Cell Transplantation - adverse effects Hematopoietic stem cells Humans Immunocompromised hosts Immunoglobulin G Incidence infection Literature reviews Patients Prophylaxis Protozoa Retrospective Studies Serological tests Stem cell transplantation Stem cells Sulfamethoxazole Toxoplasma Toxoplasmosis Toxoplasmosis - epidemiology Transplantation Transplantation, Autologous - adverse effects Trimethoprim |
| Title | Clinical characteristics and incidence of toxoplasmosis after autologous hematopoietic stem cell transplantation: A retrospective study and literature review |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Ftid.13726 https://www.ncbi.nlm.nih.gov/pubmed/34542220 https://www.proquest.com/docview/2612689734 https://www.proquest.com/docview/2574736602 |
| Volume | 23 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3PSyMxFMeDePKyq-judrdKFA97mTLNr87oSXSLCnqQCh4WhiSTgbLdSWmnIP4v_q--l_mB3R8g3gpJm2n6XvJN-t7nEXKsHcsLVciIp0MdCStUZGAVjIrUWZfnTCQCc4dvbtXlvbh-kA8b5LTNhan5EN2FG3pGWK_RwbVZvnLyapoPhnzEELeNsVooiO46dBTaWRoOWylYAuzRDVUIo3i6d67vRX8JzHW9Gjac8Ufys33UOs7k12BVmYF9-oPi-M7vsk0-NEKUntWWs0M2XLlLnhtM6IzadZAz1WVO8Vo-lCClvqCVf_RzkN6__XIKzVhqnOpVqIbrV0saWLB-7qeYJEmRFk3xPwJaBZj6TNcZT-UJPaMLVy18m_FJA-82DDfriM-0TrDZI_fjH5Pzy6gp4BBZAZ4dMZ4jD487Kw3ThTQ5T0wspVZaukJaCYJhVGjOnFAu53ASMkImqR0WCehObfknsln60n0h1MUu0bFTzrBU2NQYCe1CgH4z8KlW9sj39qfMbEM3xyIbs6w95cAcZ2GOe-So6zqvkR7_6tRv7SFrvHqZIW5NJemIix457JrBH3ECdelgejNYAsWIKxWzHvlc21E3ChcSb9xieNhgDf8fPptcXYQXX9_e9RvZYhhwE2Jt-mSzWqzcPiimyhwE13gB88QW5A |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwEB4tywEuPMSrywIGceCSKvWrCeKyAlZd2N0D6kp7QZHtOFJFias2lVb8F_4rM85DlIeEuEWyEzuTGfvzZOYbgJfG87LSlUpEPjGJdFInFlfBpMq982XJZSYpd_jsXM8u5IdLdbkHb_pcmJYfYnC4kWXE9ZoMnBzSP1l5syjHEzHl-hpcp4re8UD1aSCPIk3L43ErR13AXbrjFaI4nuHW3d3oN4i5i1jjlnN8Gz73k20jTb6Mt40du2-_8Dj-79vcgVsdFmVHrfLchT1f34PvHVPokrldLmdm6pKRZz5WIWWhYk24CitE31_DZoHNVG2cmW0siBu2GxbpYMMqLChPkhFhNKPfBKyJfOpL0yY91a_ZEVv7Zh36pE8WKW_jcMuB9Jm1OTb34eL4_fztLOlqOCROonEnXJREiSe8U5abStlSZDZVymijfKWcQswwrYzgXmpfCjwMWamy3E2qDKGnceIB7Neh9o-A-dRnJvXaW55Ll1ursF1KhHAWn-rUCF7137JwHcE51dlYFv1BB2VcRBmP4MXQddWyevyp02GvEEVn2JuCGNd0lk-FHMHzoRlNkgRoao_iLXAVlFOhdcpH8LBVpGEUIRU53VKcbFSHvw9fzE_exYuDf-_6DG7M5menxenJ-cfHcJNT_E0MvTmE_Wa99U8QQDX2abSTHzvnGv8 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zi9RAEC7WFcQXD7xmXbUVH3zJkOlrEn1aHIddj0VkF_ZBCH3C4JgeZjKw-F_8r1Z3DhwPEN8C3Ul3KlXdX3WqvgJ4rhy1XnqRsXKiMm64zDSugpkvnXHWUl7wmDv84VQen_O3F-JiD171uTAtP8Rw4BYtI63X0cBX1v9k5M3CjidsSuUVuMplXkSVnn0auKOiopXJ2ypRFXCT7miFYhjPcOvuZvQbwtwFrGnHmd-Ez_1c20CTL-Nto8fm2y80jv_5MrfgRodEyVGrOrdhz9V34HvHE7okZpfJmajakngun2qQkuBJEy7DCrH317BZYHOsNU7UNpXDDdsNSWSwYRUWMUuSRLpoEn8SkCaxqS9Vm_JUvyRHZO2adehTPkkivE3DLQfKZ9Jm2NyF8_mbs9fHWVfBITMcTTujzEZCPOaM0FR5oS0rdC6Ekko4L4xAxDD1ilHHpbMMXSHNRVGaiS8QeCrD7sF-HWr3AIjLXaFyJ52mJTel1gLbOUcAp_GpRozgRf8pK9PRm8cqG8uqd3NQxlWS8QieDV1XLafHnzod9vpQdWa9qSLfmizKKeMjeDo0o0FGAaraoXgrXAP5lEmZ0xHcb_VoGIVxEY_ccpxs0oa_D1-dnczSxcG_d30C1z7O5tX7k9N3D-E6jcE3Ke7mEPab9dY9QvTU6MfJSn4AA_0Ztw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+characteristics+and+incidence+of+toxoplasmosis+after+autologous+hematopoietic+stem+cell+transplantation%3A+A+retrospective+study+and+literature+review&rft.jtitle=Transplant+infectious+disease&rft.au=Kitahara%2C+Mari&rft.au=Hiroshima%2C+Yuki&rft.au=Norose%2C+Kazumi&rft.au=Hikosaka%2C+Kenji&rft.date=2021-12-01&rft.issn=1398-2273&rft.eissn=1399-3062&rft.volume=23&rft.issue=6&rft.epage=n%2Fa&rft_id=info:doi/10.1111%2Ftid.13726&rft.externalDBID=10.1111%252Ftid.13726&rft.externalDocID=TID13726 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1398-2273&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1398-2273&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1398-2273&client=summon |